25 May 2013
Keywords: update, msd, suspended, abpi, months, second, firm
Article | 09 October 2006
Following last week's report (Marketletter October 2) that Merck Sharp & Dohme, the UK subsidary of US-headquartered drug major Merck & Co, had
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 2006
24 May 2013
© 2013 thepharmaletter.com